Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes? Shawn S. Groth,

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Improving health care by embracing Systems Theory

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Ground glass opacity of the lung: The veil that needs lifting

Murray H. Kwon, MD The Journal of Thoracic and Cardiovascular Surgery

William M. DeCampli, MD, PhD

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

Shawn S. Groth, MD, Bryan M. Burt, MD

The lord of the rings Antonio Miceli, MD, PhD

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Gastric conduit revision after esophagectomy: The raising of Lazarus

Conduit conundrum: If not two, why three?

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Support Your Specialty

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Get it right the first time

Shawn S. Groth, MD, MS, R. Taylor Ripley, MD, Bryan M. Burt, MD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon

Is endoluminal vacuum therapy “sponge worthy”?

We are the company we keep: The importance of the tumor microenvironment Sai Yendamuri, MD, FACS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

How much is enough to warrant prophylactic tricuspid repair?

Prognosis and “granularity”: Building on staging foundations?

Who is your plastic surgeon

Functional tricuspid pathology: To treat or not to treat

Innovation in cardiothoracic surgical training

Jason J. Han, MD, Pavan Atluri, MD

First nights, the adrenal axis, and steroids

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Hope should not spring eternal

Bicuspid aortopathy: Seeing the forest for the trees

Postoperative medication management after surgical ablation: Clarifying the role of amiodarone therapy Hersh Maniar, MD, Eric Novak, MS The Journal.

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Toward a more rational approach in treating type B aortic dissection

Managing conflicts of interest

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

More than vital: Who bears the burden?

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Edward Y. Chan, MD, Michael J. Reardon, MD

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Calpain inhibitors: The aspirin of the 21st century?

Presentation transcript:

Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes? Shawn S. Groth, MD, MS, FACS The Journal of Thoracic and Cardiovascular Surgery Volume 157, Issue 3, Pages 1260-1261 (March 2019) DOI: 10.1016/j.jtcvs.2018.10.041 Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Shawn S. Groth, MD, MS, FACS The Journal of Thoracic and Cardiovascular Surgery 2019 157, 1260-1261DOI: (10.1016/j.jtcvs.2018.10.041) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions